Tendersinfo Gulf

Filter Search

Europe

Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8/130c Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Iron(iii) Oxide-sucrose Complex (b03ac02) as Part Of A So-called Open-house Model. 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-12-31
Norway Qualification For Participation In Contests For Passenger Transport On The Norwegian Railway Network 2026-12-31
Czech Republic Dynamic Purchasing System For Making Fve Feasibility Studies 2026-12-31
Germany Doxycycline (immediate-release Oral Drf; Excluding 100 Mg, 200 Mg)_tk, Hek, Hkk 2026-12-31
Slovenia Dynamic Purchasing System For Purchasing Promotional Material 2026-12-31
Germany Openhousebiologics Discount Agreements 202410 Pertuzumab / Trastuzumab (drug Combination) 2026-12-31
Germany Abschluss Nicht Exkl. Arzneimittel-rabattvereinb. Nach § 130a Abs. 8 Sgb V Im Wege Eines Open-house-modells Zum Wirkstoff Tiotropium Bromid (atc-code Nach Who: R03bb04) 2026-12-31
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a Paragraph 8 Of The Social Code Book V For The Active Substances Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. - Candesartan 2026-12-31
Germany Ciclesonid_tk, Hek, Hkk 2026-12-31
Whats app